SEC Company Response from Surgery Partners, Inc. (SGRY) (CIK 0001638833) (SGRY) — Sep 21, 2015
Surgery Partners, Inc. (SGRY) (CIK 0001638833)
Date: Sept. 21, 2015 · CIK: 0001638833 · Accession: 0001193125-15-323829
AI Filing Summary & Sentiment
Reasoning
Referenced dates: September 17, 2015
Letter
VIA EDGAR AND OVERNIGHT DELIVERY United States Securities and Exchange Commission Division of Corporation Finance Washington, D.C. 20549 Re: Surgery Partners, Inc. Amendment No. 1 to Registration Statement on Form S-1, filed on September 14, 2015 CIK No.
Dear Ms. Hayes:
On behalf of Surgery Partners, Inc. (the “Company”), set forth below are the Company’s responses to the comments of the staff (the “Staff”) of the Securities and Exchange Commission (the “SEC”) received by letter, dated September 17, 2015, relating to the Company’s Amendment No. 1 to Registration Statement on Form S-1 filed to the SEC on September 14, 2015.
The Company is concurrently filing via EDGAR Amendment No. 2 to Registration Statement on Form S-1 (the “Registration Statement”), which reflects the Company’s responses to the comments received by the Staff and certain updated information. For your convenience, the Company is also delivering a hard copy of this letter together with courtesy copies of the Registration Statement marked to show changes from the version filed on September 14, 2015.
For your convenience, the text of each of the Staff’s comments is set forth in italics below, followed in each case by the Company’s response in regular type. Page number references in our responses refer to the Registration Statement. The responses and information described below are based upon information provided to us by the Company.
Ms. Suzanne Hayes
United States Securities and Exchange Commission
September 21,
Page
Risk Factors, page 21
1. We note that your amended and restated certificate of incorporation includes an exclusive forum provision as Article IX naming the Court of Chancery for the State of Delaware as the exclusive forum for the actions described in the Article. Under an appropriately titled risk factor, please describe the exclusive forum provision and the types of actions to which it relates and disclose that such a provision may limit a shareholder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with the company and its directors, officers or other employees and may discourage lawsuits with respect to such claims.
Response to Comment 1:
The Company has revised the Registration Statement to add an appropriately titled risk factor describing the exclusive forum provision and the types of actions to which it relates and disclosing that such a provision may limit a shareholder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with the Company and its directors, officers or other employees and may discourage lawsuits with respect to such claims. Please see the revisions on page 57.
Ms. Suzanne Hayes
United States Securities and Exchange Commission
September 21,
Page
If you have any questions or comments about this letter or need any further information, please call the undersigned at (212) 841-0623.
Very truly yours,
/s/ Carl Marcellino
Show Raw Text
CORRESP 1 filename1.htm CORRESP ROPES & GRAY LLP 1211 AVENUE OF THE AMERICAS NEW YORK, NY 10036-8704 WWW.ROPESGRAY.COM September 21, 2015 VIA EDGAR AND OVERNIGHT DELIVERY Suzanne Hayes United States Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, D.C. 20549 Re: Surgery Partners, Inc. Amendment No. 1 to Registration Statement on Form S-1, filed on September 14, 2015 CIK No. 0001638833 Dear Ms. Hayes: On behalf of Surgery Partners, Inc. (the “Company”), set forth below are the Company’s responses to the comments of the staff (the “Staff”) of the Securities and Exchange Commission (the “SEC”) received by letter, dated September 17, 2015, relating to the Company’s Amendment No. 1 to Registration Statement on Form S-1 filed to the SEC on September 14, 2015. The Company is concurrently filing via EDGAR Amendment No. 2 to Registration Statement on Form S-1 (the “Registration Statement”), which reflects the Company’s responses to the comments received by the Staff and certain updated information. For your convenience, the Company is also delivering a hard copy of this letter together with courtesy copies of the Registration Statement marked to show changes from the version filed on September 14, 2015. For your convenience, the text of each of the Staff’s comments is set forth in italics below, followed in each case by the Company’s response in regular type. Page number references in our responses refer to the Registration Statement. The responses and information described below are based upon information provided to us by the Company. Ms. Suzanne Hayes United States Securities and Exchange Commission September 21, 2015 Page 2 Risk Factors, page 21 1. We note that your amended and restated certificate of incorporation includes an exclusive forum provision as Article IX naming the Court of Chancery for the State of Delaware as the exclusive forum for the actions described in the Article. Under an appropriately titled risk factor, please describe the exclusive forum provision and the types of actions to which it relates and disclose that such a provision may limit a shareholder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with the company and its directors, officers or other employees and may discourage lawsuits with respect to such claims. Response to Comment 1: The Company has revised the Registration Statement to add an appropriately titled risk factor describing the exclusive forum provision and the types of actions to which it relates and disclosing that such a provision may limit a shareholder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with the Company and its directors, officers or other employees and may discourage lawsuits with respect to such claims. Please see the revisions on page 57. Ms. Suzanne Hayes United States Securities and Exchange Commission September 21, 2015 Page 3 If you have any questions or comments about this letter or need any further information, please call the undersigned at (212) 841-0623. Very truly yours, /s/ Carl Marcellino Carl Marcellino cc: Michael Doyle Teresa Sparks